DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $154,652 | +22.7% | 11,970 | -0.1% | 0.12% | +17.3% |
Q1 2023 | $126,030 | -55.1% | 11,980 | -65.3% | 0.10% | -58.6% |
Q4 2022 | $280,856 | -45.0% | 34,530 | -42.5% | 0.24% | -50.1% |
Q3 2022 | $511,000 | -26.7% | 60,076 | -9.5% | 0.48% | -16.1% |
Q2 2022 | $697,000 | +36.1% | 66,376 | +40.4% | 0.57% | +45.9% |
Q1 2022 | $512,000 | -3.4% | 47,270 | +24.8% | 0.39% | -2.3% |
Q4 2021 | $530,000 | +180.4% | 37,880 | +97.3% | 0.40% | +151.3% |
Q2 2021 | $189,000 | +52.4% | 19,200 | +52.4% | 0.16% | +37.4% |
Q1 2021 | $124,000 | – | 12,600 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |